« Back

Management team

Keith has traveled cross country eight times and seen all 49 states, except Alaska. Since COVID started, his family has traveled to Kenya, Egypt, Jordan, Honduras, Ecuador, Peru and Belize.
Executive Vice President, Early Development

Dr. Wilcoxen is a translational leader with more than 25 years of experience advancing new therapies through preclinical and early clinical development.

Prior to joining Rome, Dr. Wilcoxen served as Senior Vice President, Global Research at Zenas BioPharma where he oversaw non-clinical development, Bioanalytical sciences and Translational medicine. Prior to Zenas, he was the Vice President of Diligence and Non-Clinical Development, followed by Vice President of Translational Research at Boston Pharmaceuticals where he was a core member of the Research & Development Leadership team. Dr. Wilcoxen has 25 years of experience in the biopharmaceutical industry including the successful submission of multiple investigational new drug applications (NDAs) and BLAs. He was a significant contributor to the development of Varubi, Zejula and Jemberli. He previously held roles of increasing responsibility in non-clinical drug development and discovery with TESARO, Eisai, Neurocrine Biosciences, and Pfizer.